X0202 4 2006-01-04 1 0001013351 MAXIM PHARMACEUTICALS INC MAXM 0001306376 Prunty John D C/O MAXIM PHARMACEUTICALS, INC. 8899 UNIVERSITY CENTER LANE SAN DIEGO CA 92122 0 1 0 0 Chief Financial Officer Common Stock 2006-01-04 4 D 0 4042 D 0 D Employee Stock Option (Right to Buy) 2.86 2006-01-04 4 D 0 5000 D 2012-11-20 Common Stock 5000 0 D Employee Stock Option (Right to Buy) 6.72 2006-01-04 4 D 0 5000 D 2013-11-20 Common Stock 5000 0 D Employee Stock Option (Right to Buy) 2.30 2006-01-04 4 D 0 100000 D 2014-10-19 Common Stock 100000 0 D Employee Stock Option (Right to Buy) 1.77 2006-01-04 4 D 0 50000 D 2015-03-08 Common Stock 50000 0 D Employee Stock Option (Right to Buy) 5.05 2006-01-04 4 D 0 15000 D 2011-09-10 Common Stock 15000 0 D Employee Stock Option (Right to Buy) 5.82 2006-01-04 4 D 0 5000 D 2011-11-20 Common Stock 5000 0 D Disposed of pursuant to an Agreement and Plan of Merger among issuer, EpiCept Corporation and Magazine Acquisition Corp., dated September 6, 2005, in exchange for 0.203969 shares of EpiCept common stock and cash for fractional shares of EpiCept common stock equal to approximately $1.134 per share. Because there was no public market for the EpiCept common stock at the effective time of the merger, the market value of such stock was not determinable. The option vests 25% per year over 4 years. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 1,019 shares of EpiCept common stock for $14.03 per share. The option vests 25% per year over 4 years. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 1,019 shares of EpiCept common stock for $32.95 per share. The option vests 25% per year over 4 years. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 20,396 shares of EpiCept common stock for $11.28 per share. The option vests 100% over 6 months. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 10,198 shares of EpiCept common stock for $8.68 per share. The option vests 25% per year over 4 years. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 3,059 shares of EpiCept common stock for $24.76 per share. The option vests 25% per year over 4 years. This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 1,019 shares of EpiCept common stock for $28.54 per share. /s/ John D. Prunty 2006-01-06